Section Arrow
Quote
BSEM.NASDAQ
- Biostem Technologies Inc
Quotes are at least 15-min delayed:2026/11/06 19:04 EST
After Hours
Last
 1
-0.13 (-11.50%)
Bid
1.03
Ask
1.12
High 1.13 
Low 1 
Volume 187 
Regular Hours (Closed)
Last
 1.13
+0.09 (+8.65%)
Day High 
1.15 
Prev. Close
1.04 
1-M High
2.79 
Volume 
100.82K 
Bid
1.03
Ask
1.12
Day Low
1.01 
Open
1.03 
1-M Low
1.01 
Market Cap 
19.42M 
Currency 美元 
P/E 1.18 
%Yield -- 
10-SMA 1.3 
20-SMA 1.65 
50-SMA 2.87 
52-W High 8.4 
52-W Low 1.01 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.88/-1.04
Enterprise Value
19.75M
Balance Sheet
Book Value Per Share
1.48
Cash Flow
Cash Flow Yield
0.62
Income Statement
Total Revenue
1.02M
Operating Revenue Per Share
0.28
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
KPTIKaryopharm Therapeutics Inc.0.0549-0.0052-8.65%-- 
After Hours 0.0455 -0.0094 -17.12%
INOInovio Pharmaceuticals1.215-0.235-16.21%-- 
After Hours 1.23 +0.015 +1.23%
LABTLakewood-Amedex Biotherapeutics Inc0.3863-0.1543-28.54%-- 
After Hours 0.387 +0.0007 +0.18%
CDTCdt Equity Inc1.31+0.464+54.85%0PE
After Hours 1.17 -0.14 -10.69%
MRNAModerna254.19+12.73+5.27%-- 
After Hours 256.51 +2.32 +0.91%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.